PetVivo (PETV) Competitors $0.95 -0.08 (-7.77%) As of 02:43 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsHeadlinesInsider TradesSEC FilingsTrendsBuy This Stock PETV vs. NSPR, OBIO, ZJYL, FONR, BDMD, EDAP, NTRB, APYX, VANI, and ICCMShould you be buying PetVivo stock or one of its competitors? The main competitors of PetVivo include InspireMD (NSPR), Orchestra BioMed (OBIO), Jin Medical International (ZJYL), Fonar (FONR), Baird Medical Investment (BDMD), EDAP TMS (EDAP), Nutriband (NTRB), Apyx Medical (APYX), Vivani Medical (VANI), and IceCure Medical (ICCM). These companies are all part of the "medical equipment" industry. PetVivo vs. Its Competitors InspireMD Orchestra BioMed Jin Medical International Fonar Baird Medical Investment EDAP TMS Nutriband Apyx Medical Vivani Medical IceCure Medical InspireMD (NYSE:NSPR) and PetVivo (NASDAQ:PETV) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their dividends, valuation, analyst recommendations, media sentiment, profitability, institutional ownership, earnings and risk. Do analysts prefer NSPR or PETV? InspireMD presently has a consensus target price of $4.50, indicating a potential upside of 89.08%. Given InspireMD's stronger consensus rating and higher probable upside, research analysts plainly believe InspireMD is more favorable than PetVivo.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score InspireMD 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00PetVivo 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Is NSPR or PETV more profitable? InspireMD has a net margin of -413.96% compared to PetVivo's net margin of -902.82%. InspireMD's return on equity of -69.42% beat PetVivo's return on equity.Company Net Margins Return on Equity Return on Assets InspireMD-413.96% -69.42% -57.68% PetVivo -902.82%-4,813.07%-281.78% Which has better valuation and earnings, NSPR or PETV? PetVivo has lower revenue, but higher earnings than InspireMD. InspireMD is trading at a lower price-to-earnings ratio than PetVivo, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioInspireMD$7.07M14.05-$19.92M-$0.83-2.87PetVivo$1.05M26.56-$10.95M-$0.40-2.38 Does the media favor NSPR or PETV? In the previous week, InspireMD and InspireMD both had 1 articles in the media. InspireMD's average media sentiment score of 0.26 beat PetVivo's score of 0.00 indicating that InspireMD is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment InspireMD 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral PetVivo 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Which has more volatility and risk, NSPR or PETV? InspireMD has a beta of 0.68, meaning that its share price is 32% less volatile than the S&P 500. Comparatively, PetVivo has a beta of 0.75, meaning that its share price is 25% less volatile than the S&P 500. Do institutionals and insiders believe in NSPR or PETV? 44.8% of InspireMD shares are owned by institutional investors. Comparatively, 24.5% of PetVivo shares are owned by institutional investors. 29.7% of InspireMD shares are owned by insiders. Comparatively, 10.8% of PetVivo shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth. SummaryInspireMD beats PetVivo on 10 of the 15 factors compared between the two stocks. Get PetVivo News Delivered to You Automatically Sign up to receive the latest news and ratings for PETV and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding PETV and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart PETV vs. The Competition Export to ExcelMetricPetVivoSurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$27.79M$70.60M$5.65B$10.30BDividend YieldN/AN/A5.68%4.61%P/E Ratio-2.1110.7975.8526.09Price / Sales26.5635.66514.78169.46Price / CashN/A18.4137.5661.52Price / Book-31.6715.1212.886.30Net Income-$10.95M-$25.86M$3.29B$271.03M7 Day Performance-5.00%-1.66%-0.25%-0.14%1 Month Performance18.97%1.43%3.88%6.44%1 Year Performance90.50%66.26%68.42%28.85% PetVivo Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)PETVPetVivoN/A$0.95-7.8%N/A+106.1%$27.79M$1.05M-2.1120News CoverageHigh Trading VolumeNSPRInspireMD3.445 of 5 stars$2.41+1.3%$4.50+86.7%-12.0%$100.55M$7.07M-3.2150Positive NewsOBIOOrchestra BioMed2.9749 of 5 stars$2.53-2.7%$13.50+433.6%-47.5%$100.47M$2.64M-1.384Positive NewsZJYLJin Medical InternationalN/A$0.62-0.9%N/A-80.1%$98.08M$23.50M0.00245Positive NewsGap UpFONRFonar1.2323 of 5 stars$15.47-0.3%N/A-11.9%$96.22M$102.88M12.38480Earnings ReportUpcoming EarningsHigh Trading VolumeBDMDBaird Medical InvestmentN/A$2.66+2.3%N/AN/A$92.89MN/A0.00N/APositive NewsGap DownEDAPEDAP TMS2.2846 of 5 stars$2.33-3.3%$8.50+264.8%-16.4%$90.11M$69.18M-3.82230NTRBNutriband2.9421 of 5 stars$7.15+6.1%$13.00+81.8%+8.5%$81.11M$2.14M-2.4910APYXApyx Medical2.3507 of 5 stars$2.13flatN/A+72.3%$80.56M$48.10M-4.73270Positive NewsVANIVivani Medical3.4086 of 5 stars$1.21-4.7%$4.00+230.6%+22.5%$75.24MN/A-2.6920News CoveragePositive NewsICCMIceCure Medical2.3911 of 5 stars$1.02-5.6%$2.39+133.8%+71.3%$74.19M$3.29M-6.3860 Related Companies and Tools Related Companies NSPR Alternatives OBIO Alternatives ZJYL Alternatives FONR Alternatives BDMD Alternatives EDAP Alternatives NTRB Alternatives APYX Alternatives VANI Alternatives ICCM Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:PETV) was last updated on 9/25/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredA New Way to Double Your Retirement Income?Bloomberg reports that a new class of investments is “entering a golden era,” with yields fueling a retail boo...Investors Alley | SponsoredForget NVDA. Put $1,000 into this stock nowA massive money shift is underway in the AI market. And it's opening up an extraordinary opportunity in a NEW ...Chaikin Analytics | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | SponsoredWarren Buffett’s #1 AI Stock: Not Mag 7, And NOT on the NasdaqNew Amazon Crisis Could Tank U.S. Stock Market A new panic is halting AI projects at Amazon and could split...Altimetry | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding PetVivo Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share PetVivo With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
